Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy

NAActive, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 12, 2011

Primary Completion Date

October 17, 2022

Study Completion Date

November 30, 2025

Conditions
Adenoid Cystic CarcinomaSquamous Cell CarcinomaSinonasal CarcinomaSinonasal Undifferentiated CarcinomaMucoepidermoid CarcinomaSchneiderian CarcinomaMyoepithelial CarcinomaEsthesioneuroblastomaMelanoma
Interventions
RADIATION

Proton radiation therapy

Daily proton radiation therapy

RADIATION

Intensity-modulated radiotherapy

Daily intensity-modulated radiotherapy

Trial Locations (2)

55905

Mayo Clinic Rochester, Rochester

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT01586767 - Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy | Biotech Hunter | Biotech Hunter